SK Bioscience Co

SK Bioscience Co ROA

The Return on Assets (ROA) of SK Bioscience Co (302440.KS) as of Nov 5, 2026 is -1.94 %. In the previous year, Return on Assets (ROA) was -1.89 % — a change of 2.53% (lower).

ROA

-1.94 %

YoY

2.53%

Last updated:

In 2025, SK Bioscience Co's return on assets (ROA) was -1.94 %, a 2.53% increase from the -1.89 % ROA in the previous year.

The SK Bioscience Co ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
0.10 KRW
Jan 1, 2019
3.63 KRW
Jan 1, 2020
5.85 KRW
Jan 1, 2021
16.83 KRW
Jan 1, 2022
5.72 KRW
Jan 1, 2023
1.20 KRW
Jan 1, 2024
-1.89 KRW
Jan 1, 2025
-1.94 KRW
The SK Bioscience Co ROA history
YEARROAYoY
-1.94 %+2.53%
-1.89 %-257.28%
1.20 %-78.93%
5.72 %-66.03%
16.83 %+187.70%
5.85 %+61.01%
3.63 %+3,376.68%
0.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SK Bioscience Co Stock analysis

What does SK Bioscience Co do? SK Bioscience Co Ltd is a South Korean biotechnology company headquartered in Seongnam, Gyeonggi-Do. The company went public on March 18, 2021, with its stock listed on the Korean Stock Exchange under the ticker 302440.KS. It operates within the health care sector, specifically in the biotechnology industry. SK Bioscience employs 1,067 people and focuses on the development and distribution of bio and vaccine products. The company distributes its products both domestically and internationally. While specific product names are mentioned in unverified sources, the company is known to be involved in the production of vaccines and infusion solutions. It also engages in technology export business, though detailed information about its technology or export markets is not provided. The company's website is https://www.skbioscience.co.kr/, where further information about its operations and products may be available. SK Bioscience does not disclose specific details about its product lines beyond the general categories of vaccines and infusion solutions, and it does not provide information on acquisitions, founding year, or key personnel. The company's activities are centered around biotechnology and healthcare, with a focus on vaccine development and distribution. Its market presence spans both domestic and international markets, though specific regions or countries are not specified. The company's financial data, including revenue and market capitalization, is not included in the provided information. SK Bioscience is a publicly traded company with a focus on biotechnology and healthcare innovation. SK Bioscience Co is one of the most popular companies on Eulerpool.

ROA Details

Understanding SK Bioscience Co's Return on Assets (ROA)

SK Bioscience Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing SK Bioscience Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider SK Bioscience Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in SK Bioscience Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about SK Bioscience Co stock

Return on Assets (ROA) of SK Bioscience Co is -1.94 % in 2025.

Return on Assets (ROA) of SK Bioscience Co changed from -1.89 % to -1.94 %, representing a 2.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) SK Bioscience Co since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s SK Bioscience Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — SK Bioscience Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — SK Bioscience Co